Related Experiment Video
Updated: Jun 21, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs
Peng Zhan1, Zhenyu Li, Xinyong Liu
1Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44, West Culture Road, 250012, Jinan, Shandong, P.R.China.
Abstract:
There is an urgent need for the design and development of new and safer drugs for the treatment of human immunodeficiency virus (HIV) infection, specifically active against drug-resistant viral strains. Recently, sulfanyltriazole/tetrazole derivatives were reported as potent HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs), with low nanomolar intrinsic activity against RT and submicromolar antiviral activity in HIV infected cells. In this review, the structural modifications, SAR analysis and docking studies of sulfanyltriazole/tetrazoles HIV-1 NNRTIs are discussed, and other interesting NNRTIs with the same or similar pharmacophore as the sulfanyltriazole/tetrazole derivatives are also presented and analyzed for their in SAR.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Oral Hypoglycemic Agents: Sulfonylureas
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Antihypertensive Drugs: Thiazide-Class Diuretics
